A First Principle Study on Geometrical and Electronic Properties of Chlorpheniramine: An Anti-Allergic Drug

Read full text Summarise with VIRAT
Authors: Ram Naresh Singh1, Arun Kumar2*, Ratnesh Kumar3
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In the present work, a comprehensive first-principles investigation of the geometrical and electronic properties of chlorpheniramine, a widely used anti-allergic drug, has been carried out using density functional theory (DFT). The optimized molecular geometry of chlorpheniramine was obtained at the B3LYP/6-311++G(d,p) level of theory, and the structural parameters were analyzed to understand the stability and molecular configuration of the compound. The electronic properties were examined through frontier molecular orbital (FMO) analysis, including the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO). The HOMO–LUMO energy gap provides valuable insight into the chemical stability, reactivity, and charge transfer characteristics of the molecule. Furthermore, the molecular electrostatic potential (MESP) surface was mapped to identify the electron-rich and electron-deficient regions responsible for possible electrophilic and nucleophilic interactions. The MESP analysis reveals the distribution of electrostatic potential over the molecular surface, highlighting the potential reactive sites within the drug molecule. The combined geometrical optimization, HOMO–LUMO analysis, and MESP mapping provide a detailed understanding of the electronic structure and reactivity of chlorpheniramine. These theoretical findings contribute to a deeper insight into the physicochemical behavior of chlorpheniramine and may be useful for further pharmacological and molecular design studies related to anti-allergic drugs.

Fields of Study & Subjects

Advanced Chemical Physics Studies Computational Drug Discovery Methods Free Radicals and Antioxidants

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN